The Government of India is in no mood to ban the use of nimesulide for pediatric purpose in the country. In a written reply to a question by Ramanaidu Duggubati in Lok Sabha on February 18, 2003, Dr. Chhattra Pal Singh, Minister of State for Chemicals and Fertilizers stated that majority of the experts within the country have confirmed the reliability and safety of the drug.

He informed that a detailed examination has been undertaken by an Expert Committee (Sub-Committee) of Drug Technical Advisory Board to deliberate on the issues concerning the safety of nimesulide, including its use in children. "More than 20 expert paediatricians across the country and the Indian Academy of Paediatrics (IAP) were consulted. Majority of experts have confirmed the reliability of nimesulide and no serious adverse reaction in children have been reported in the country," he stated.

The minister also explained that the drug has not been banned in almost all countries. The use of nimesulide is reported to have been suspended only in Spain, Turkey and Finland. Nimisulide, a non-steroidal anti-inflammatory drug (NSAID), is reported to be used in about 50 countries including India and is indicated for acute pain/inflammation and fever. In India, the drug was approved in 1995, and it is a prescription drug, he informed.